The longer the antithyroid drug is used, the lower the relapse rate in Graves’ disease: a retrospective multicenter cohort study in Korea

被引：0
|
作者：
So Young Park
Bo Hyun Kim
Mijin Kim
A.Ram Hong
Jun Park
Hyunju Park
Min Sun Choi
Tae Hyuk Kim
Sun Wook Kim
Ho-Cheol Kang
Jae Hoon Chung
机构：
[1] Sungkyunkwan University School of Medicine,Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center
[2] Korea University Ansan Hospital,Division of Endocrinology, Department of Medicine
[3] Pusan National University Hospital,Division of Endocrinology and Metabolism, Department of Internal Medicine, Biomedical Research Institute
[4] Chonnam National University Medical School,Department of Internal Medicine
来源：
Endocrine | 2021年 / 74卷
关键词：
Grave’s disease; Hyperthyroidism; Antithyroid agents; Treatment outcome; Recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：120 / 127
页数：7
相关论文
共 50 条
  • [1] The longer the antithyroid drug is used, the lower the relapse rate in Graves' disease: a retrospective multicenter cohort study in Korea
    Park, So Young
    Kim, Bo Hyun
    Kim, Mijin
    Hong, A. Ram
    Park, Jun
    Park, Hyunju
    Choi, Min Sun
    Kim, Tae Hyuk
    Kim, Sun Wook
    Kang, Ho-Cheol
    Chung, Jae Hoon
    ENDOCRINE, 2021, 74 (01) : 120 - 127
  • [2] PROSPECTIVE MULTICENTER STUDY ON THE PREDICTION OF RELAPSE AFTER ANTITHYROID DRUG-TREATMENT IN PATIENTS WITH GRAVES-DISEASE
    SCHLEUSENER, H
    SCHWANDER, J
    FISCHER, C
    HOLLE, R
    HOLL, G
    BADENHOOP, K
    HENSEN, J
    FINKE, R
    BOGNER, U
    MAYR, WR
    SCHERNTHANER, G
    SCHATZ, H
    PICKARDT, CR
    KOTULLA, P
    ACTA ENDOCRINOLOGICA, 1989, 120 (06): : 689 - 701
  • [3] When should antithyroid drug therapy to reduce the relapse rate of hyperthyroidism in Graves' disease be discontinued?
    Park, Suyeon
    Song, Eyun
    Oh, Hye-Seon
    Kim, Mijin
    Jeon, Min Ji
    Kim, Won Gu
    Kim, Tae Yong
    Shong, Young Kee
    Kim, Doo Man
    Kim, Won Bae
    ENDOCRINE, 2019, 65 (02) : 348 - 356
  • [4] Relapse of Graves' disease in Chinese children: a retrospective cohort study
    Cui, Yiyun
    Chen, Jinlong
    Guo, Rui
    Yang, Ruize
    Chen, Dandan
    Gu, Wei
    Bigambo, Francis Manyori
    Wang, Xu
    EUROPEAN THYROID JOURNAL, 2023, 12 (03)
  • [5] When should antithyroid drug therapy to reduce the relapse rate of hyperthyroidism in Graves’ disease be discontinued?
    Suyeon Park
    Eyun Song
    Hye-Seon Oh
    Mijin Kim
    Min Ji Jeon
    Won Gu Kim
    Tae Yong Kim
    Young Kee Shong
    Doo Man Kim
    Won Bae Kim
    Endocrine, 2019, 65 : 348 - 356
  • [6] Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment
    Liu, Xingjun
    Shi, Bingyin
    Li, Hao
    ANNALES D ENDOCRINOLOGIE, 2015, 76 (06) : 679 - 683
  • [7] Genotype and Phenotype Predictors of Relapse of Graves' Disease after Antithyroid Drug Withdrawal
    Wang, Pei-Wen
    Chen, I-Ya
    Juo, Suh-Hang Hank
    Hsi, Edward
    Liu, Rue-Tsuan
    Hsieh, Ching-Jung
    EUROPEAN THYROID JOURNAL, 2012, 1 (04) : 251 - 258
  • [8] Remission in pediatric Graves' disease treated with antithyroid drug and the risk factors associated with relapse
    Wong, Tsz Wai Catherine
    Wong, Man Yee Shirley
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2022, 27 (04) : 308 - 314
  • [9] Can hyperthyroidism relapse after antithyroid drug treatment be predicted in children with Graves disease?
    Stephen A Huang
    Nature Clinical Practice Endocrinology & Metabolism, 2009, 5 : 74 - 75
  • [10] Can hyperthyroidism relapse after antithyroid drug treatment be predicted in children with Graves disease?
    Huang, Stephen A.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2009, 5 (02): : 74 - 75
12345